These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32014559)

  • 1. Prolong antiplatelet therapy. Where we stand?
    Tousoulis D
    Hellenic J Cardiol; 2019; 60(5):269-270. PubMed ID: 32014559
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical assessment of the preventive use of antiplatelet drugs].
    Lozano Almela ML; Vicente García V
    Rev Clin Esp; 2004 Feb; 204(2):106-8. PubMed ID: 15023312
    [No Abstract]   [Full Text] [Related]  

  • 3. Current concepts in antiplatelet therapy for cardiovascular disease.
    Martinez A
    JAAPA; 2004 Mar; 17(3):16-20, 23-4; quiz 51-2. PubMed ID: 15314880
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial: Paving the way for improved antiplatelet therapy.
    Grove EL
    Curr Pharm Des; 2012; 18(33):5195-6. PubMed ID: 22724421
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiplatelet medications: old and emerging therapies.
    Stone WM; Naidu SG; Chapital A; Money SR
    Ann Vasc Surg; 2010 Jan; 24(1):140-8. PubMed ID: 19619976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The brave new world of antiplatelet therapy: seeking clarity in a world of increasing choice and complexity.
    Price MJ
    Rev Cardiovasc Med; 2011; 12 Suppl 1():S1-3. PubMed ID: 22080982
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical importance of antiplatelet drugs in cardiovascular diseases.
    Papp J; Kenyeres P; Toth K
    Clin Hemorheol Microcirc; 2013; 53(1-2):81-96. PubMed ID: 22954637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet agents: current drugs and future trends.
    Messmore HL; Jeske WP; Wehrmacher W; Coyne E; Mobarhan S; Cho L; Leya FS; Moran JF
    Hematol Oncol Clin North Am; 2005 Feb; 19(1):87-117, vi. PubMed ID: 15639110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet Signaling Pathways and New Inhibitors.
    Grover SP; Bergmeier W; Mackman N
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):e28-e35. PubMed ID: 29563117
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease.
    Wang TY; Angiolillo DJ; Cushman M; Sabatine MS; Bray PF; Smyth SS; Dauerman HL; French PA; Becker RC
    J Am Coll Cardiol; 2012 Mar; 59(10):891-900. PubMed ID: 22381424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antiplatelet therapy on platelet extracellular vesicle release and procoagulant activity in health and in cardiovascular disease.
    Connor DE; Ly K; Aslam A; Boland J; Low J; Jarvis S; Muller DW; Joseph JE
    Platelets; 2016 Dec; 27(8):805-811. PubMed ID: 27310292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should we monitor platelet function during antiplatelet therapy?
    Hjemdahl P
    Heart; 2008 Jun; 94(6):685-7. PubMed ID: 18480343
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic and acquired determinants of individual variability of response to antiplatelet drugs.
    Schafer AI
    Circulation; 2003 Aug; 108(8):910-1. PubMed ID: 12939239
    [No Abstract]   [Full Text] [Related]  

  • 14. Monitoring oral antiplatelet therapy: is it justified?
    Ang L; Mahmud E
    Ther Adv Cardiovasc Dis; 2008 Dec; 2(6):485-96. PubMed ID: 19124443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet function and antiplatelet therapy in cardiovascular disease: implications of genetic polymorphisms.
    Shanker J; Gasparyan AY; Kitas GD; Kakkar VV
    Curr Vasc Pharmacol; 2011 Jul; 9(4):479-89. PubMed ID: 21314637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined antiplatelet therapy: still a sweeping combination in cardiology.
    Manolis AS; Manolis TA; Papadimitriou P; Koulouris S; Melita H
    Cardiovasc Hematol Agents Med Chem; 2013 Jun; 11(2):136-67. PubMed ID: 23597106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet function testing as a biomarker for efficacy of antiplatelet drugs.
    Lordkipanidzé M; So D; Tanguay JF
    Biomark Med; 2016 Aug; 10(8):903-18. PubMed ID: 27414976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiology patient page. Platelets and cardiovascular disease.
    Gregg D; Goldschmidt-Clermont PJ
    Circulation; 2003 Sep; 108(13):e88-90. PubMed ID: 14517153
    [No Abstract]   [Full Text] [Related]  

  • 19. Clopidogrel: to test or not to test? That is the question--still.
    Cannon CP
    Clin Chem; 2011 May; 57(5):659-61. PubMed ID: 21402801
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological inhibition of platelet reactivity. Clinical and pharmacodynamic effects.
    Vallés J; Moscardo A; Madrid I; Santos MT
    Curr Vasc Pharmacol; 2013 Jul; 11(4):431-47. PubMed ID: 23905638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.